Production of steviol glycosides in recombinant hosts

• US 10,815,514 B2
• Filed: 05/16/2017
• Issued: 10/27/2020
• Est. Priority Date: 05/16/2016
• Status: Active Grant

• Current Assignee: Evolva Holding SA
• Original Assignee: Evolva Holding SA
• Inventors: Olsson, Kim, Sheridan, Joseph Michael, Recorda, Laura Tatjer, Nyffengger, Christian, Douchin, Veronique
• Primary Examiner(s): Tsay, Marsha
• Application Number:
  US16/098,347
• Publication Number:
  US 20190153495A1
• Time in Patent Office: 1,260 Days
• Field of Search: None
• CPC Class Codes: C12N 9/1048 Glycosyltransferases (2.4)
• CPC Class Codes: C12N 9/1051 Hexosyltransferases (2.4.1)
• CPC Class Codes: C12P 19/56 having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Abstract

The invention relates to recombinant microorganisms and methods for producing steviol glycosides, glycosides of steviol precursors, and steviol glycoside precursors.

Claims

1. An in vitro method for producing one or more steviol glycosides and/or glycosylated steviol precursors, or a composition thereof comprising:

(a) adding a polypeptide capable of glycosylating steviol or a steviol glycoside at its C-19 carboxyl group having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

4, and further having at least one amino acid substitution at residues 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 184, 260, 286, or 377 of SEQ ID NO;

4;

and a plant-derived or synthetic steviol glycoside precursor or a plant-derived or synthetic steviol precursor to a reaction mixture; and

(b) producing the one or more steviol glycosides and/or glycosylated steviol precursors, or the composition thereof, thereby;

wherein the reaction mixture comprises (i) glucose, fructose, sucrose, xylose, rhamnose, uridine diphosphate (UDP)-glucose, UDP-rhamnose, UDP-xylose, and/or N-acetyl-glucosamine; and

(ii) reaction buffer and/or salts; and

wherein the one or more steviol glycosides and/or glycosylated steviol precursors are, or the composition thereof comprises steviol-13-O-glucoside (13-SMG), steviol-19-O-glucoside (19-SMG), steviol-1,2-bioside, steviol-1,3-bioside, 1,2-stevioside, 1,3-stevioside, rubusoside, Rebaudioside A (RebA), Rebaudioside B (RebB), Rebaudioside C (RebC), Rebaudioside D (RebD), Rebaudioside E (RebE), Rebaudioside F (RebF), Rebaudioside M (RebM), Rebaudioside Q (RebQ), Rebaudioside I (RebI), dulcoside A, a mono-glycosylated ent-kaurenoic acid, a di-glycosylated ent-kaurenoic acid, a tri-glycosylated ent-kaurenoic acid, a mono-glycosylated ent-kaurenols, a di-glycosylated ent-kaurenol, a tri-glycosylated ent-kaurenol, a tri-glycosylated steviol glycoside, a tetra-glycosylated steviol glycoside, a penta-glycosylated steviol glycoside, a hexa-glycosylated steviol glycoside, a hepta-glycosylated steviol glycoside, or an isomer thereof.

2. The method of claim 1, further comprising:

(c) recovering the one or more steviol glycosides and/or glycosylated steviol precursors, or the composition thereof from the reaction mixture.

3. The method of claim 1, wherein:

(a) the di-glycosylated ent-kaurenoic acid comprises ent-kaurenoic acid+2Glc (#7);

(b) the tri-glycosylated ent-kaurenoic acid comprises ent-kaurenoic acid+3Glc (isomer

     1) or ent-kaurenoic acid+3Glc (isomer

     2);

(c) the di-glycosylated ent-kaurenol comprises ent-kaurenol+2Glc (#8);

(d) the tri-glycosylated ent-kaurenol comprises ent-kaurenol+3Glc (isomer

     1) or ent-kaurenol+3Glc (#6);

(e) the steviol glycoside comprises 13-SMG, 19-SMG, steviol-1,2-bioside, steviol-1,3-bioside, rubusoside, RebA, RebE, RebD or RebM;

(f) the tetra-glycosylated steviol comprises steviol+4Glc (#26) or steviol+4Glc (#33);

(g) the penta-glycosylated steviol comprises steviol+5Glc (#24) or steviol+5Glc (#25);

(h) the hexa-glycosylated steviol comprises steviol+6Glc (isomer

     1) or steviol+6Glc (#23); and

(i) the hepta-glycosylated steviol comprises steviol+7Glc (isomer

     2) or steviol+7Glc (isomer

     5).

4. The method of claim 1, wherein the polypeptide comprises a M79V, M79E, S80C, A81W, E83K, A81W and E83K, H184V, H184T, N260T, K286C, N260T and K286C, K286E, K286N, K286T, and/or S377Q amino acid substitution of SEQ ID NO:

4.

5. The method of claim 1, wherein one or more of a polypeptide capable of beta 1,3 glycosylation of the C3′

of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside, a polypeptide capable of beta 1,2 glycosylation of the C2′

of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside, a polypeptide capable of glycosylating steviol or a steviol glycoside at its C-13 hydroxyl group, or a polypeptide capable of glycosylating steviol or a steviol glycoside at its C-19 carboxyl group are further added to the reaction mixture, wherein;

(a) the polypeptide capable of glycosylating steviol or the steviol glycoside at its C-13 hydroxyl group thereof comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

7;

(b) the polypeptide capable of beta 1,3 glycosylation of the C3′

of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of the steviol glycoside comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

9;

(c) the polypeptide capable of glycosylating steviol or the steviol glycoside at its C-19 carboxyl group thereof comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

4; and

(d) the polypeptide capable of beta 1,2 glycosylation of the C2′

of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of the steviol glycoside comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

16 or a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO;

11 or 13.

6. The method of claim 1, wherein the polypeptide capable of glycosylating steviol or the steviol glycoside at its C-19 carboxyl group further comprises a tag sequence having at least 90% identity to any one of SEQ ID NOs:

152-155.